Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction

被引:0
作者
Maria Ida Maiorino
Giuseppe Bellastella
Michela Petrizzo
Elisabetta Della Volpe
Rosanna Orlando
Dario Giugliano
Katherine Esposito
机构
[1] University Hospital at Second University of Naples,Endocrinology and Metabolic Diseases Unit, Department of Medical, Surgical, Neurological, Metabolic Science and Geriatrics
[2] Centro Direzionale,IOS and Coleman – Medicina Futura Medical Center
[3] Second University of Naples,Department of Clinical and Experimental Medicine
来源
Endocrine | 2015年 / 49卷
关键词
Endothelial progenitor cells; Type 1 diabetes; Erectile dysfunction; Testosterone;
D O I
暂无
中图分类号
学科分类号
摘要
Circulating endothelial progenitor cells (EPCs) are bone marrow-derived stem cells able to migrate to sites of damaged endothelium and differentiate into endothelial cells, thereby contributing to vascular repair. Recent studies demonstrated a reduction of EPCs in patients with diabetes mellitus or erectile dysfunction (ED). The aim of this study was to evaluate the circulating levels of different EPCs phenotypes and their relation with testosterone levels in young type 1 diabetic patients with ED. We studied 118 consecutively type 1 diabetic patients and 60 age-matched healthy controls. Erectile function was assessed by completing the International Index of Erectile Function (IIEF-5) and EPCs levels by flow cytometry. Testosterone concentrations were evaluated in all the study population. We identified 38 diabetic patients with ED (Group 1) and 80 patients without ED (Group 2). CD34+KDR+CD133+ cells were significantly lower in patients in Group 1 as compared with those in Group 2 [median and interquartile range, n/106 events, 12 (6–16) vs. 18 (13–22), P < 0.001)]. In all participants in the study, there was a significant correlation between circulating CD34+KDR+CD133+ cells and testosterone levels (r = 0.410, P < 0.001), which was highest in Group 1, intermediate in Group 2, and lowest in Group 3 (controls). There was a significant correlation between IIEF-5 score and both CD34+KDR+ (r = 0.459, P = 0.003) and CD34+KDR+CD133+ (r = 0.316, P = 0.050) cells among patients of Group 1, as well as between testosterone levels and most of the EPCs phenotypes. Finally, multivariate regression analysis identified levels of circulating CD34+KDR+ cells as an independent risk factor for ED (β-coefficient 0.348, P = 0.007). In conclusion, type 1 diabetic patients with ED show reduced levels of CD34+KDR+CD133+ cells, whose number correlates with IIEF. Further studies are needed to fully understand the exact mechanisms by which testosterone regulates vascular homeostasis.
引用
收藏
页码:415 / 421
页数:6
相关论文
共 259 条
  • [1] Fedele D(1998)Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici Diabetes Care 21 1973-1977
  • [2] Coscelli C(2002)Association of type and duration of diabetes with erectile dysfunction in a large cohort of men Diabetes Care 25 1458-1463
  • [3] Santeusanio F(2014)Prediabetes and associated disorders Endocrine 46 423-430
  • [4] Bortolotti A(2014)Endocrine evaluation of erectile dysfunction Endocrine 18 732-738
  • [5] Chatenoud L(2001)Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients Diabet. Med. 5 2125-2134
  • [6] Colli E(2008)Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido J. Sex. Med. 22 204-209
  • [7] Landoni M(2010)Determinants of erectile dysfunction in type 2 diabetes Int. J. Impot. Res. 70 81-89
  • [8] Parazzini F(2005)Prevalence and risk factors for erectile dysfunction in Japanese diabetics Diabetes Res. Clin. Pract. 25 129-136
  • [9] Bacon CG(2011)Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management J. Diabetes Complicat. 58 1378-1385
  • [10] Hu FB(2011)Erectile dysfunction and risk of cardiovascular disease meta-analysis of prospective cohort studies J. Am. Coll. Cardiol. 43 285-292